Ergoteles’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,360,987
Closed -$1.58M 2243
2022
Q2
$1.58M Buy
1,360,987
+454,857
+50% +$475K 0.05% 380
2022
Q1
$979K Buy
+906,130
New +$684K 0.04% 434

Ergoteles's MBII Position: Q3 2022 in Review

Ergoteles sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 1,360,987 shares — an estimated $1.58M sold.

Ergoteles first reported a position in MBII in Q1 2022 and held it in 2 quarters. The position peaked at $1.58M in Q2 2022. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

  • Ergoteles reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
  • Ergoteles sold 1,360,987 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $1.58M.
  • Ergoteles first reported a position in Marrone Bio Innovations, Inc. in Q1 2022 and held it in 2 quarters.
  • Ergoteles's Marrone Bio Innovations, Inc. position peaked at $1.58M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.